Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Listener feedback, statin eligibility and Yogi Berra, evidence-based medicine and heterogenous treatment effects, and MRAs in HF are the topics John Mandrola, MD, discusses in this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I. Listener Feedback
- ASPIRE AF https://classic.clinicaltrials.gov/ct2/show/NCT03968393
- Butala paper: Stroke After TAVR With and Without EPD https://www.ahajournals.org/doi/abs/10.1161/CIRCINTERVENTIONS.123.013697
- PROTECTED TAVR
- Heuts meta-analysis: EPD During TAVR https://heart.bmj.com/content/110/11/757
II. Statin Eligibility
- JAMA-IM: Data Analytic Choices and Predicting Vascular Events https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2819821
- Zeraatker Specification Analysis Paper https://doi.org/10.1016/j.jclinepi.2024.111278
- PCE https://www.mdcalc.com/calc/3398/ascvd-atherosclerotic-cardiovascular-disease-2013-risk-calculator-aha-acc
III. Heterogenous Treatment Effect
- Weisberg and Dailey-Higgs
- DANISH
IV. Heart Failure and MRAs
- RALES https://www.nejm.org/doi/full/10.1056/NEJM199909023411001
- EMPHASIS https://www.nejm.org/doi/full/10.1056/NEJMoa1009492
- Combined analysis (Matsumoto)
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]